Table 9.
Plasmid types found in percentage of clinical isolates
| Target plasmid | C. portucalensis | E. hormaechei | E. coli | K. pneumoniae | Total no. isolates found in |
|---|---|---|---|---|---|
| Col(pHAD28) | 0 (0.0%) | 5 (100%) | 0 (0.0%) | 0 (0.0%) | 5 (17.9%) |
| Col156 | 0 (0.0%) | 0 (0.0%) | 9 (90.0%) | 0 (0.0%) | 9 (32.1%) |
| Col440I | 1 (100%) | 0 (0.0%) | 2 (20.0%) | 12 (100%) | 15 (53.6%) |
| Col440II | 1 (100%) | 1 (20.0%) | 2 (20.0%) | 12 (100%) | 16 (57.1%) |
| ColKP3 | 1 (100%) | 0 (0.0%) | 1 (10.0%) | 10 (83.3%) | 12 (42.9%) |
| IncC | 1 (100%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (3.6%) |
| IncFIA | 0 (0.0%) | 0 (0.0%) | 9 (90.0%) | 11 (91.7%) | 20 (71.4%) |
| IncFIB(AP001918) | 0 (0.0%) | 0 (0.0%) | 9 (90.0%) | 9 (75.0%) | 18 (64.3%) |
| IncFIB(K) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (8.3%) | 1 (3.6%) |
| IncFIB(pQil) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 11 (91.7%) | 11 (39.3%) |
| IncFII | 0 (0.0%) | 0 (0.0%) | 9 (90.0%) | 4 (33.3%) | 13 (46.4%) |
| IncFII(K) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 11 (91.7%) | 11 (39.3%) |
| IncHI1A(NDM-CIT) | 1 (100%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (3.6%) |
| IncHI1B(pNDM-CIT) | 1 (100%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (3.6%) |
| IncHI2 | 0 (0.0%) | 0 (0.0%) | 1 (10.0%) | 1 (8.3%) | 2 (7.1%) |
| IncHI2A | 0 (0.0%) | 0 (0.0%) | 1 (10.0%) | 1 (8.3%) | 2 (7.2% |
| IncL | 1 (100%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (3.6%) |
| IncR | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (8.3%) | 1 (3.6%) |
| IncX3 | 0 (0.0%) | 5 (100%) | 0 (0.0%) | 11 (91.7%) | 16 (57.1%) |
| p0111 | 0 (0.0%) | 0 (0.0%) | 1 (10.0%) | 0 (0.0%) | 1 (3.6%) |
Col440II was the only plasmid found across all clinical isolate species. IncFIB(AP001918) was the most commonly identified plasmid